Literature DB >> 2675409

Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis.

P M Taylor1, M L Rose, M H Yacoub.   

Abstract

Immunocytochemical techniques have been used to investigate the expression of common determinants of class I, common determinants of class II and DR, DP, and DQ antigens on frozen sections from twenty normal donor lungs, three lungs resected due to carcinoma and nine lungs removed from heart/lung recipients who were undergoing retransplant due to obliterative bronchiolitis. In all lungs, alveolar macrophages expressed common determinants of class I and class II, as well as DR, DP and DQ antigens. In normal lung, class I was expressed on all vascular endothelium, all tracheal epithelium and most, but not all, bronchiolar epithelium. Class II was always expressed on tracheal epithelium, but expression on bronchiolar epithelium and vascular endothelium was variable and sometimes absent. In lungs from transplant patients with severe obliterative bronchiolitis, vascular endothelium, in addition to expressing class I, now consistently expressed class II. Epithelium from trachea, bronchioles, and alveoli also consistently expressed class I and class II. To conclude, there is enhanced expression of class II antigens on endothelial and epithelial cells from lungs with obliterative bronchiolitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675409     DOI: 10.1097/00007890-198909000-00030

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Authors:  Cassandra L Mikols; Le Yan; Jin Y Norris; Tonya D Russell; Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Roger D Yusen; Mario Castro; Elbert Kuo; G Alexander Patterson; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

Review 2.  Optimal delivery of vaccines: clinical pharmacokinetic considerations.

Authors:  S Gizurarson
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

3.  Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.

Authors:  Takeshi Mimura; Natalie Walker; Yoshiro Aoki; Casey M Manning; Benjamin J Murdock; Jeffery L Myers; Amir Lagstein; John J Osterholzer; Vibha N Lama
Journal:  Am J Pathol       Date:  2015-04-04       Impact factor: 4.307

4.  Cell-cell and cell-matrix adhesion molecules in human heart and lung transplants.

Authors:  G Steinhoff; A Haverich
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

5.  Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts.

Authors:  Shinji Nakashima; T Rinda Soong; Karen Fox-Talbot; Zhiping Qian; Salma Rahimi; Barbara A Wasowska; Charles A Rohde; Sabrina Chen; Joe G N Garcia; William M Baldwin
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

6.  Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome.

Authors:  John R Greenland; Kirk D Jones; Steve R Hays; Jeffrey A Golden; Anatoly Urisman; Nicholas P Jewell; George H Caughey; Neil N Trivedi
Journal:  Am J Respir Crit Care Med       Date:  2012-12-13       Impact factor: 21.405

7.  Bronchiolitis obliterans in ataxia-telangiectasia.

Authors:  M Ito; A Nakagawa; N Hirabayashi; J Asai
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

8.  Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus.

Authors:  L Ibrahim; M Dominguez; M Yacoub
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

9.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Methods Mol Biol       Date:  2013

10.  Antigenic heterogeneity of vascular endothelium.

Authors:  C Page; M Rose; M Yacoub; R Pigott
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.